The Canadian Rheumatology Association would like to advise its members of the following reported drug shortage:
Drug Name: Shingrix – Herpes Zoster Vaccine
Expected Resolution of Shortage: December 31, 2018
Provinces Affected: National
Additional Comments: High demand for the drug coupled with the variable timing of supply shipments. Limited supply available of Shingrix 10s.
- January 18, 2019 Update: High demand for the drug coupled with the variable timing of supply shipments. Re-supply is ongoing with current inventory on allocation.
- Supply of Shingrix in the 10 dose package size were released on November 26 and are available under allocation – Read more
- Limited supply of the 1 dose package size is anticipated to be available in mid-December – Read more